Personal assessment of the external exposome during pregnancy and childhood in Europe.

Black carbon Childhood Dynamic modelling Green spaces Particulate matter Personal exposure monitoring Physical activity Pregnancy Ultraviolet radiation

Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
07 2019
Historique:
received: 23 10 2018
revised: 14 04 2019
accepted: 15 04 2019
pubmed: 6 5 2019
medline: 8 1 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

The human exposome affects child development and health later in life, but its personal external levels, variability, and correlations are largely unknown. We characterized the personal external exposome of pregnant women and children in eight European cities. Panel studies included 167 pregnant women and 183 children (aged 6-11 years). A personal exposure monitoring kit composed of smartphone, accelerometer, ultraviolet (UV) dosimeter, and two air pollution monitors were used to monitor physical activity (PA), fine particulate matter (PM

Identifiants

pubmed: 31055170
pii: S0013-9351(19)30224-5
doi: 10.1016/j.envres.2019.04.015
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-104

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

David Donaire-Gonzalez (D)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

Ariadna Curto (A)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Antònia Valentín (A)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Sandra Andrusaityte (S)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Xavier Basagaña (X)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Maribel Casas (M)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Leda Chatzi (L)

Department of Preventive Medicine, University of Southern California, Los Angeles, USA; Department of Genetics & Cell Biology, Maastricht University, the Netherlands.

Jeroen de Bont (J)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Montserrat de Castro (M)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Audrius Dedele (A)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Berit Granum (B)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Regina Grazuleviciene (R)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Mariza Kampouri (M)

Department of Social Medicine, University of Crete, Greece.

Sarah Lyon-Caen (S)

Institut National de la Santé et de la Recherche Médicale (Inserm), CNRS, Univ. Grenoble Alpes, Institute for Advanced Biosciences (IAB), U1209, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, La Tronche, France.

Cyntia B Manzano-Salgado (CB)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Gunn Marit Aasvang (GM)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Rosemary McEachan (R)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust (BTHFT), Bradford, United Kingdom.

Carin Helena Meinhard-Kjellstad (CH)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Eirini Michalaki (E)

Department of Social Medicine, University of Crete, Greece.

Pau Pañella (P)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Inga Petraviciene (I)

Department of Environmental Sciences, Vytautas Magnus University, Kaunas, Lithuania.

Per E Schwarze (PE)

Norwegian Institute of Public Health (NIPH), Oslo, Norway.

Rémy Slama (R)

Institut National de la Santé et de la Recherche Médicale (Inserm), CNRS, Univ. Grenoble Alpes, Institute for Advanced Biosciences (IAB), U1209, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, La Tronche, France.

Oliver Robinson (O)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, United Kingdom.

Ibon Tamayo-Uria (I)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and "Instituto de Investigación Sanitaria de Navarra (IdISNA)", Pamplona, Spain.

Marina Vafeiadi (M)

Department of Social Medicine, University of Crete, Greece.

Dagmar Waiblinger (D)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust (BTHFT), Bradford, United Kingdom.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust (BTHFT), Bradford, United Kingdom.

Martine Vrijheid (M)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.

Mark J Nieuwenhuijsen (MJ)

ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Electronic address: mark.nieuwenhuijsen@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH